Veterinary Cytology Schoolhouse, LLC – Trademark Portfolio
Entity Type: 16
Veterinary Cytology Schoolhouse, LLC holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include VETHIVE. The owner is based in Nashville, TN.
222 Second Avenue North, Suite 340-M
Nashville, TN 37201
Showing of trademarks Trademarks
Trademark Classifications
Veterinary Cytology Schoolhouse, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Veterinary Cytology Schoolhouse, LLC have?
Veterinary Cytology Schoolhouse, LLC has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Veterinary Cytology Schoolhouse, LLC file in?
Veterinary Cytology Schoolhouse, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 9 (Computers & Electronics). Class 35 covers advertising; business management; business administration; office functions.
What are Veterinary Cytology Schoolhouse, LLC's most well-known trademarks?
Veterinary Cytology Schoolhouse, LLC's registered trademark portfolio includes well-known marks such as VETHIVE. These are among 1 currently registered trademark in the portfolio.
What is Veterinary Cytology Schoolhouse, LLC's trademark registration success rate?
Veterinary Cytology Schoolhouse, LLC has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.